Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Leukemia

  Free Subscription


17.02.2025

1 Am J Clin Pathol
5 Am J Hematol
2 Ann Hematol
1 Ann Oncol
3 Blood
1 BMC Cancer
3 Bone Marrow Transplant
1 Cancer
1 Eur J Haematol
1 J Natl Cancer Inst
3 Leuk Lymphoma
1 Leuk Res
1 Oncogene
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Pathol

  1. ROSHAL M, Gao Q
    Flow cytometry evaluation of acute myeloid leukemia minimal residual disease based on an understanding of the normal maturation patterns in the blast compartments.
    Am J Clin Pathol. 2025 Feb 8:aqae187. doi: 10.1093.
    PubMed         Abstract available


    Am J Hematol

  2. SU W, Stricherz M, Martin A, Belsey J, et al
    The Efficacy of Pediatric-Inspired Regimens vs. Hyper-CVAD in the Treatment of Adolescents and Young Adults With Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.
    Am J Hematol. 2025 Feb 13. doi: 10.1002/ajh.27607.
    PubMed         Abstract available

  3. SHIMONY S, Stahl M, Stone RM
    Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management.
    Am J Hematol. 2025 Feb 12. doi: 10.1002/ajh.27625.
    PubMed         Abstract available

  4. CANALI A, Rieu JB, Lapierre L, Bain BJ, et al
    BCR::ABL1-Positive Acute Myeloid Leukemia.
    Am J Hematol. 2025 Feb 11. doi: 10.1002/ajh.27633.
    PubMed        

  5. ITONAGA H, Miyazaki Y, Kondo T, Shimazu Y, et al
    Long-Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1-Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for Transplantation
    Am J Hematol. 2025 Feb 11. doi: 10.1002/ajh.27641.
    PubMed        

  6. SENAPATI J, Loghavi S, Marvin-Peek J, Garcia-Manero G, et al
    Clinico-Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies.
    Am J Hematol. 2025 Feb 8. doi: 10.1002/ajh.27628.
    PubMed         Abstract available


    Ann Hematol

  7. IBERTI M, Loschi M, Keslair F, Deckert M, et al
    Novel ETV6::RAPGEF6 fusion gene in chronic eosinophilic leukemia: compiling evidence on the role of IL3 overexpression in tumorigenesis.
    Ann Hematol. 2025 Feb 9. doi: 10.1007/s00277-025-06217.
    PubMed         Abstract available

  8. IYAMA S, Chi S, Idogawa M, Ikezoe T, et al
    Prognostic impact of TET2 mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study.
    Ann Hematol. 2025 Feb 8. doi: 10.1007/s00277-025-06227.
    PubMed         Abstract available


    Ann Oncol

  9. MUSTO P, Engelhardt M, van de Donk NWCJ, Gay F, et al
    European Myeloma Network Group Review and Consensus Statement on Primary Plasma Cell Leukemia.
    Ann Oncol. 2025 Feb 7:S0923-7534(25)00058-4. doi: 10.1016/j.annonc.2025.
    PubMed         Abstract available


    Blood

  10. SILVA HJ, Martin G, Birocchi F, Wehrli M, et al
    CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML.
    Blood. 2025;145:720-731.
    PubMed         Abstract available

  11. PARISI X, Loghavi S
    Acute erythroid leukemia or acute myeloid leukemia with mutated TP53? The battle of phenotype versus genotype.
    Blood. 2025;145:784.
    PubMed        

  12. SHAH V, Giotopoulos G, Osaki H, Meyerhofer M, et al
    Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivation.
    Blood. 2025;145:748-764.
    PubMed         Abstract available


    BMC Cancer

  13. WANG Y, Zhang TJ, Zhang LC, Xu ZJ, et al
    Overexpression and oncogenic role of RIPK3 in acute myeloid leukemia associated with specific subtypes and treatment outcome.
    BMC Cancer. 2025;25:253.
    PubMed         Abstract available


    Bone Marrow Transplant

  14. SANZ J, Labopin M, Versluis J, Blaise D, et al
    Cytogenetic and molecular risk-driven conditioning intensity in acute myeloid leukemia patients undergoing stem cell transplantation with post-transplant cyclophosphamide: a study from the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2025 Feb 12. doi: 10.1038/s41409-025-02527.
    PubMed         Abstract available

  15. SHAFFER BC, Kebriaei P, de Lima M, Jimenez Jimenez AM, et al
    Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice.
    Bone Marrow Transplant. 2025;60:128-134.
    PubMed         Abstract available

  16. GOMEZ-ARTEAGA A, Chokr N, Auletta JJ
    Precision medicine results from equitable representation.
    Bone Marrow Transplant. 2025;60:122-127.
    PubMed         Abstract available


    Cancer

  17. GYAN E, Minden MD, Kubo K, Rambaldi A, et al
    Maintenance therapy with the FMS-like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS-like tyrosine kinase 3-internal tandem duplication acute myeloid leukemia: A phase 2 study.
    Cancer. 2025;131:e35746.
    PubMed         Abstract available


    Eur J Haematol

  18. ROBAK T, Robak M, Majchrzak A, Krawczynska A, et al
    Atypical Hairy Cell Leukemia-The Current Status and Future Directions.
    Eur J Haematol. 2025 Feb 10. doi: 10.1111/ejh.14388.
    PubMed         Abstract available


    J Natl Cancer Inst

  19. PECHLIVANOGLOU P, Luu L, Li Q, Rios JD, et al
    Development of a policy model for pediatric acute lymphoblastic leukemia to facilitate economic evaluation.
    J Natl Cancer Inst. 2025 Feb 14:djaf024. doi: 10.1093.
    PubMed         Abstract available


    Leuk Lymphoma

  20. SUN Y, Liu N, Liu Y, Deng J, et al
    Isolated CNS B lymphoid/myeloid bilineage relapse following allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with KMT2A::MLLT1 rearrangement.
    Leuk Lymphoma. 2025 Feb 10:1-4. doi: 10.1080/10428194.2025.2460046.
    PubMed        

  21. THOMAS CJ, Porter D, Van Deerlin VM, Bhattacharyya S, et al
    Aleukemic soft-tissue relapse post allogeneic hematopoietic cell transplantation in T-prolymphocytic leukemia.
    Leuk Lymphoma. 2025 Feb 8:1-4. doi: 10.1080/10428194.2025.2462950.
    PubMed        

  22. LANG F, Voss A, Kobbe G, Junghanss C, et al
    Final analysis of the GMALL-PH-01 trial: phase II study of standard chemotherapy in combination with dasatinib in first line treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.
    Leuk Lymphoma. 2025 Feb 8:1-9. doi: 10.1080/10428194.2025.2460737.
    PubMed         Abstract available


    Leuk Res

  23. KOMROKJI Z, Ali NA, Xie Z, Chan O, et al
    Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML).
    Leuk Res. 2025;150:107662.
    PubMed         Abstract available


    Oncogene

  24. ZHANG J, Zhai J, Wong CC, Chen H, et al
    Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304.
    PubMed        


    Proc Natl Acad Sci U S A

  25. WANG JY, Gui TT, Jiao B, Liu X, et al
    Metabolomic insights into pathogenesis and therapeutic potential in adult acute lymphoblastic leukemia.
    Proc Natl Acad Sci U S A. 2025;122:e2423169122.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.